MedEquities Realty Trust Inc (NYSE:MRT) Director Bluemountain Capital Managemen sold 25,765 shares of the business’s stock in a transaction that occurred on Tuesday, November 6th. The stock was sold at an average price of $8.58, for a total value of $221,063.70. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Bluemountain Capital Managemen also recently made the following trade(s):

  • On Thursday, November 8th, Bluemountain Capital Managemen sold 35,783 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.60, for a total value of $307,733.80.
  • On Friday, November 2nd, Bluemountain Capital Managemen sold 25,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.39, for a total value of $209,750.00.
  • On Wednesday, October 31st, Bluemountain Capital Managemen sold 10,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.45, for a total value of $84,500.00.
  • On Monday, October 29th, Bluemountain Capital Managemen sold 11,695 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.39, for a total value of $98,121.05.
  • On Thursday, October 25th, Bluemountain Capital Managemen sold 25,546 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.45, for a total value of $215,863.70.
  • On Monday, October 22nd, Bluemountain Capital Managemen sold 5,463 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.65, for a total value of $47,254.95.
  • On Friday, October 19th, Bluemountain Capital Managemen sold 5,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.54, for a total value of $42,700.00.
  • On Wednesday, October 17th, Bluemountain Capital Managemen sold 23,200 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.84, for a total value of $205,088.00.
  • On Friday, October 12th, Bluemountain Capital Managemen sold 10,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.74, for a total value of $87,400.00.
  • On Monday, October 15th, Bluemountain Capital Managemen sold 21,289 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.80, for a total value of $187,343.20.

Shares of NYSE MRT opened at $8.73 on Friday. MedEquities Realty Trust Inc has a one year low of $8.25 and a one year high of $12.00. The firm has a market capitalization of $271.79 million, a price-to-earnings ratio of 7.11 and a beta of 0.65.

MedEquities Realty Trust (NYSE:MRT) last issued its quarterly earnings data on Wednesday, August 8th. The financial services provider reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.20). MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. The firm had revenue of $17.56 million during the quarter, compared to analyst estimates of $17.03 million. Equities research analysts predict that MedEquities Realty Trust Inc will post 1.08 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. American Century Companies Inc. grew its holdings in MedEquities Realty Trust by 7.1% in the 3rd quarter. American Century Companies Inc. now owns 2,325,880 shares of the financial services provider’s stock valued at $22,608,000 after buying an additional 153,969 shares in the last quarter. BlackRock Inc. grew its holdings in MedEquities Realty Trust by 14.8% in the 3rd quarter. BlackRock Inc. now owns 1,721,509 shares of the financial services provider’s stock valued at $16,733,000 after buying an additional 222,015 shares in the last quarter. Renaissance Technologies LLC grew its holdings in MedEquities Realty Trust by 36.0% in the 2nd quarter. Renaissance Technologies LLC now owns 839,800 shares of the financial services provider’s stock valued at $9,255,000 after buying an additional 222,500 shares in the last quarter. Eagle Boston Investment Management Inc. grew its holdings in MedEquities Realty Trust by 3.8% in the 3rd quarter. Eagle Boston Investment Management Inc. now owns 812,689 shares of the financial services provider’s stock valued at $7,899,000 after buying an additional 29,828 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its holdings in MedEquities Realty Trust by 0.7% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 764,932 shares of the financial services provider’s stock valued at $8,430,000 after buying an additional 5,106 shares in the last quarter. 91.02% of the stock is currently owned by hedge funds and other institutional investors.

A number of research firms recently weighed in on MRT. B. Riley set a $12.00 target price on MedEquities Realty Trust and gave the stock a “buy” rating in a report on Thursday, August 9th. ValuEngine lowered MedEquities Realty Trust from a “sell” rating to a “strong sell” rating in a report on Friday, September 14th. Cantor Fitzgerald reissued a “neutral” rating and set a $10.00 target price (down from $12.00) on shares of MedEquities Realty Trust in a report on Friday, September 28th. Canaccord Genuity decreased their target price on MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, August 9th. Finally, Royal Bank of Canada set a $10.00 target price on MedEquities Realty Trust and gave the stock a “hold” rating in a report on Sunday, August 12th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company’s stock. MedEquities Realty Trust currently has a consensus rating of “Hold” and a consensus target price of $11.25.

COPYRIGHT VIOLATION WARNING: “MedEquities Realty Trust Inc (MRT) Director Sells $221,063.70 in Stock” was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.dailypolitical.com/2018/11/10/medequities-realty-trust-inc-mrt-director-sells-221063-70-in-stock.html.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

See Also: What is a bull market?

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.